The Association Between Higher Expression of Talin-۱ and the Reduced Survival Rate in Ovarian Serous Carcinoma Patients

Publish Year: 1402
نوع سند: مقاله ژورنالی
زبان: English
View: 77

This Paper With 15 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IJP-18-3_009

تاریخ نمایه سازی: 14 شهریور 1402

Abstract:

Background & Objective: Talin-۱ is a constituent of the multiprotein adhesion complexes that play  main role in the formation of tumors and migration in different types of malignancies. The present study aimed to assess  expression and prognostic significance of the talin-۱ protein in ovarian serous carcinoma (OSC) patients.Methods: The expression of talin-۱ in mRNA and its protein levels were investigated for ovarian cancer (OC) by using bioinformatics tools, including Gene Expression Profiling Interactive Analysis ۲ (GEPIA۲), Gene Expression Database of Normal and Tumor Tissue ۲ (GENT۲), and The University of ALabama at Birmingham CANcer data analysis Portal (UALCAN) databases. Thereafter, immunohistochemical (IHC) staining was used to study the expression patterns of the talin-۱ protein using ۴۶ paraffin-embedded OSC tissue specimens, ۲۵ benign tumors, and ۲۰ normal tissues, which were assembled in tissue microarrays (TMAs). We also assessed the potential association between the expression of the talin-۱ protein, various clinicopathological parameters, and survival outcomes.Results: Our IHC examination for talin-۱ was significantly overexpressed in OSC tissues compared to benign tumors and normal tissues. The Kaplan-Meier survival analysis has also indicated statistically significant differences in terms of disease-specific survival (DSS) and progression-free survival (PFS) between the patients with high and low expression levels of talin-۱, respectively.Conclusion: The talin-۱ protein was overexpressed in OSC tissues, and a high expression level of talin-۱ was found to be significantly associated with tumor aggressiveness and poorer DSS or PFS. Therefore, talin-۱ may serve as a molecular marker of cancer progression and a novel prognostic biomarker in these patients.

Authors

Mina Sharbatoghli

Oncopathology Research Center, Iran University of Medical Sciences (IUMS), Tehran, Iran

Leili Saeednejad Zanjani

Oncopathology Research Center, Iran University of Medical Sciences (IUMS), Tehran, Iran

Fahimeh Fattahi

Oncopathology Research Center, Iran University of Medical Sciences (IUMS), Tehran, Iran

Elham Kalantari

Oncopathology Research Center, Iran University of Medical Sciences (IUMS), Tehran, Iran

Zohre Habibi Shams

Department of Pathology, Iran University of Medical Sciences, Tehran, Iran

Mahshid Panahi

Department of Pathology, Iran University of Medical Sciences, Tehran, Iran

Mehdi Totonchi

Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran

Mohsen Asadi-Lari

Oncopathology Research Center, Iran University of Medical Sciences (IUMS), Tehran, Iran

Zahra Majd

Oncopathology Research Center, Iran University of Medical Sciences (IUMS), Tehran, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Rock CL, Thomson C, Gansler T, Gapstur SM, McCullough ML, ...
  • Lai MT, Hua CH, Tsai MH, Wan L, Lin YJ, ...
  • Slater M, Cooper M, Murphy CR. The cytoskeletal proteins alpha-actinin, ...
  • Kobel M, Kang EY. The Evolution of Ovarian Carcinoma Subclassification. ...
  • Ji L, Jiang F, Cui X, Qin C. Talin۱ knockdown ...
  • نمایش کامل مراجع